Sheets Smith Wealth Management increased its position in Henry Schein, Inc. (NASDAQ:HSIC) by 1.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 79,010 shares of the company’s stock after buying an additional 1,000 shares during the period. Henry Schein accounts for about 1.7% of Sheets Smith Wealth Management’s investment portfolio, making the stock its 9th biggest position. Sheets Smith Wealth Management owned about 0.05% of Henry Schein worth $6,204,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. Private Advisor Group LLC purchased a new stake in Henry Schein during the second quarter valued at approximately $238,000. Dimensional Fund Advisors LP raised its position in Henry Schein by 4.6% during the second quarter. Dimensional Fund Advisors LP now owns 653,032 shares of the company’s stock valued at $47,437,000 after purchasing an additional 28,853 shares during the period. FMR LLC raised its position in Henry Schein by 167.3% during the second quarter. FMR LLC now owns 6,632,783 shares of the company’s stock valued at $481,805,000 after purchasing an additional 4,151,179 shares during the period. Federated Investors Inc. PA raised its position in Henry Schein by 50.6% during the second quarter. Federated Investors Inc. PA now owns 50,225 shares of the company’s stock valued at $3,648,000 after purchasing an additional 16,865 shares during the period. Finally, Raymond James & Associates raised its position in Henry Schein by 18.0% during the second quarter. Raymond James & Associates now owns 147,422 shares of the company’s stock valued at $10,709,000 after purchasing an additional 22,496 shares during the period.

In related news, CEO Stanley M. Bergman sold 69,000 shares of the stock in a transaction that occurred on Friday, December 7th. The stock was sold at an average price of $86.32, for a total value of $5,956,080.00. Following the transaction, the chief executive officer now owns 240,096 shares of the company’s stock, valued at $20,725,086.72. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, insider David Mckinley sold 8,321 shares of the stock in a transaction that occurred on Friday, November 30th. The stock was sold at an average price of $88.77, for a total value of $738,655.17. Following the completion of the transaction, the insider now directly owns 68,012 shares in the company, valued at approximately $6,037,425.24. The disclosure for this sale can be found here. In the last three months, insiders sold 105,856 shares of company stock worth $9,222,275. 1.15% of the stock is owned by insiders.

A number of equities research analysts have issued reports on HSIC shares. ValuEngine upgraded Henry Schein from a “strong sell” rating to a “sell” rating in a research report on Thursday, September 13th. Cleveland Research restated a “hold” rating on shares of Henry Schein in a research report on Monday, September 24th. Robert W. Baird upped their price objective on Henry Schein from $90.00 to $95.00 and gave the company an “outperform” rating in a research report on Thursday, October 4th. Zacks Investment Research upgraded Henry Schein from a “hold” rating to a “buy” rating and set a $98.00 price objective on the stock in a research report on Friday, October 5th. Finally, BidaskClub upgraded Henry Schein from a “buy” rating to a “strong-buy” rating in a research report on Saturday, October 6th. Four analysts have rated the stock with a sell rating, eight have given a hold rating and seven have issued a buy rating to the stock. Henry Schein has a consensus rating of “Hold” and an average price target of $84.93.

Shares of HSIC traded down $0.24 during mid-day trading on Friday, reaching $79.24. 65,512 shares of the company’s stock traded hands, compared to its average volume of 1,460,744. The stock has a market cap of $11.64 billion, a price-to-earnings ratio of 22.07, a P/E/G ratio of 2.40 and a beta of 0.96. Henry Schein, Inc. has a 12 month low of $62.56 and a 12 month high of $91.35. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.70 and a current ratio of 1.30.

Henry Schein (NASDAQ:HSIC) last released its earnings results on Tuesday, November 6th. The company reported $1.03 EPS for the quarter, beating analysts’ consensus estimates of $1.01 by $0.02. The firm had revenue of $3.28 billion for the quarter, compared to analysts’ expectations of $3.37 billion. Henry Schein had a return on equity of 20.40% and a net margin of 3.00%. The company’s quarterly revenue was up 3.8% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.87 earnings per share. As a group, analysts predict that Henry Schein, Inc. will post 4.12 earnings per share for the current fiscal year.

Henry Schein declared that its Board of Directors has initiated a stock repurchase program on Thursday, December 13th that permits the company to repurchase $400.00 million in outstanding shares. This repurchase authorization permits the company to buy up to 3.1% of its shares through open market purchases. Shares repurchase programs are typically an indication that the company’s leadership believes its shares are undervalued.

ILLEGAL ACTIVITY NOTICE: “Sheets Smith Wealth Management Has $6.20 Million Position in Henry Schein, Inc. (HSIC)” was first posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this article on another publication, it was illegally copied and reposted in violation of US & international trademark and copyright legislation. The legal version of this article can be viewed at https://www.thecerbatgem.com/2019/01/11/sheets-smith-wealth-management-has-6-20-million-position-in-henry-schein-inc-hsic.html.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, animal health clinics, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Read More: Market Capitalization in the Stock Market

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.